{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:20:45Z","timestamp":1791141645613,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.drudis.2009.10.005","type":"journal-article","created":{"date-parts":[[2009,10,24]],"date-time":"2009-10-24T04:54:39Z","timestamp":1256360079000},"page":"148-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["The quest for biomarkers in tuberculosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Shreemanta K.","family":"Parida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2009.10.005_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drudis.2008.03.010","article-title":"Whither antibacterial drug discovery?","volume":"13","author":"Projan","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2009.10.005_bib2","series-title":"Global Tuberculosis Control: Epidemiology, Strategy, Financing","author":"WHO","year":"2009"},{"key":"10.1016\/j.drudis.2009.10.005_bib3","series-title":"Global map and information on XDR-TB","author":"WHO","year":"2009"},{"key":"10.1016\/j.drudis.2009.10.005_bib4","volume":"Vol. 2009","author":"WHO","year":"2008"},{"key":"10.1016\/j.drudis.2009.10.005_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0307-299","article-title":"Changing funding patterns in tuberculosis","volume":"13","author":"Kaufmann","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro1688","article-title":"The contribution of immunology to the rational design of novel antibacterial vaccines","volume":"5","author":"Kaufmann","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2009.10.005_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2008.08.002","article-title":"Tuberculosis in Africa: learning from pathogenesis for biomarker identification","volume":"4","author":"Kaufmann","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drudis.2009.10.005_bib8","series-title":"Strategic Plan: Stop TB Partnership","author":"Stop TB","year":"2008"},{"key":"10.1016\/j.drudis.2009.10.005_bib9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and \u201cunmasking\u201d of tuberculosis during antiretroviral therapy","volume":"177","author":"Lawn","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.drudis.2007.08.001","article-title":"Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery","volume":"12","author":"Pepper","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2009.10.005_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.300.4.423","article-title":"Opportunities and challenges for HIV care in overlapping HIV and TB epidemics","volume":"300","author":"Havlir","year":"2008","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drudis.2009.10.005_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11904-008-0021-5","article-title":"Managing tuberculosis and HIV in sub-Sahara Africa","volume":"5","author":"Lalloo","year":"2008","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.drudis.2009.10.005_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/589248","article-title":"Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum","volume":"47","author":"Marais","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20030205","article-title":"Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program","volume":"198","author":"Voskuil","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa","volume":"16","author":"Black","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.drudis.2009.10.005_bib16","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib17","series-title":"TB Diagnostics Pipeline: New TB Diagnostics Working Group","author":"Stop TB","year":"2008"},{"key":"10.1016\/j.drudis.2009.10.005_bib18","series-title":"Foundation for Innovative New Diagnostics tuberculosis product deliverables 2008\u20132013","author":"FIND","year":"2008"},{"key":"10.1016\/j.drudis.2009.10.005_bib19","first-page":"33","article-title":"Detection of M. tuberculosis using DNA chips combined with an image analysis system","volume":"12","author":"Huang","year":"2008","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib20","series-title":"TB Vaccines Pipeline: Working Group on New TB Vaccines","author":"Stop TB","year":"2008"},{"key":"10.1016\/j.drudis.2009.10.005_bib21","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant Bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib22","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis Bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2009.10.005_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2009.10.005_bib24","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/522432","article-title":"Correlates, surrogates, and vaccines","volume":"196","author":"Sadoff","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1177\/009127000004001212","article-title":"Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development","volume":"40","author":"Colburn","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2009.10.005_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1515\/BC.2008.053","article-title":"Novel strategies to identify biomarkers in tuberculosis","volume":"389","author":"Jacobsen","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.drudis.2009.10.005_bib28","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.annepidem.2007.07.003","article-title":"Epidemiologic methods developments: a look forward to the year 2032","volume":"17","author":"Prentice","year":"2007","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.drudis.2009.10.005_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(07)70112-3","article-title":"Biomarkers of treatment response in clinical trials of novel antituberculosis agents","volume":"7","author":"Perrin","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/156652407780598566","article-title":"Transcriptional responses of Mycobacterium tuberculosis exposed to adverse conditions in vitro","volume":"7","author":"Bacon","year":"2007","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1566524053152843","article-title":"Transcriptome analysis in drug development","volume":"5","author":"Williams","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib32","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2009.10.005_bib33","first-page":"107","article-title":"Management of breast cancer \u2013 part I","volume":"337","author":"Turner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2009.10.005_bib34","first-page":"164","article-title":"Management of breast cancer \u2013 part II","volume":"337","author":"Turner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.drudis.2009.10.005_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2009.10.005_bib36","series-title":"PathogenChip","author":"PathogenChip","year":"2008"},{"key":"10.1016\/j.drudis.2009.10.005_bib37","doi-asserted-by":"crossref","first-page":"e3840","DOI":"10.1371\/journal.pone.0003840","article-title":"Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis","volume":"3","author":"Gaseitsiwe","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2009.10.005_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/346053","article-title":"Whole blood bactericidal activity during treatment of pulmonary tuberculosis","volume":"187","author":"Wallis","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib39","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/ajrccm\/147.4.1062","article-title":"Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months","volume":"147","author":"Mitchison","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(02)09742-8","article-title":"Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial","volume":"360","author":"Benator","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2009.10.005_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-0038-1633994","article-title":"Sample selection for microarray gene expression studies","volume":"44","author":"Repsilber","year":"2005","journal-title":"Methods Inf. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-007-0157-6","article-title":"Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis","volume":"85","author":"Jacobsen","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib43","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-0038-1634118","article-title":"Deconfounding microarray analysis \u2013 independent measurements of cell type proportions used in a regression model to resolve tissue heterogeneity bias","volume":"45","author":"Jacobsen","year":"2006","journal-title":"Methods Inf. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510397","article-title":"Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis","volume":"195","author":"Mistry","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02648725.1996.10647923","article-title":"Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it","volume":"13","author":"Wilkins","year":"1996","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.drudis.2009.10.005_bib46","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/cr068287r","article-title":"Serum and plasma proteomics","volume":"107","author":"Issaq","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2009.10.005_bib47","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(06)69379-3","article-title":"When does a fingerprint constitute a diagnostic?","volume":"368","author":"White","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2009.10.005_bib48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2958.1999.01549.x","article-title":"Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens","volume":"33","author":"Jungblut","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.drudis.2009.10.005_bib49","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1002\/elps.200305601","article-title":"Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen","volume":"24","author":"Mattow","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.drudis.2009.10.005_bib50","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/452920a","article-title":"Biologists initiate plan to map human proteome","volume":"452","author":"Pearson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2009.10.005_bib51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","article-title":"Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum","volume":"368","author":"Agranoff","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2009.10.005_bib52","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1002\/pmic.200401245","article-title":"HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples","volume":"5","author":"Rai","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.drudis.2009.10.005_bib53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/pr0703066","article-title":"The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways","volume":"7","author":"Wang","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.drudis.2009.10.005_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/mp.54.4.253","article-title":"Application of laser capture microdissection and proteomics in colon cancer","volume":"54","author":"Lawrie","year":"2001","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.drudis.2009.10.005_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-59745-117-8_9","article-title":"Combining laser capture microdissection and proteomics techniques","volume":"428","author":"Mustafa","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drudis.2009.10.005_bib56","series-title":"Drug Discovery: Business Briefing. PharmaTech 2004","first-page":"51","article-title":"Metabolomics \u2013 an important emerging science","author":"Ryals","year":"2004"},{"key":"10.1016\/j.drudis.2009.10.005_bib57","series-title":"Metabolic profiling: its role in biomarker discovery and gene function analysis","first-page":"311","article-title":"The human metabolome","author":"Beecher","year":"2003"},{"key":"10.1016\/j.drudis.2009.10.005_bib58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1369-5266(00)00159-X","article-title":"A systematic approach to biochemical profiling","volume":"4","author":"Glassbrook","year":"2001","journal-title":"Curr. Opin. Plant Biol."},{"key":"10.1016\/j.drudis.2009.10.005_bib59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/81137","article-title":"Metabolite profiling for plant functional genomics","volume":"18","author":"Fiehn","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2009.10.005_bib60","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2009.10.005_bib61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tube.2008.01.002","article-title":"The scent of Mycobacterium tuberculosis","volume":"88","author":"Syhre","year":"2008","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.drudis.2009.10.005_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tube.2009.04.003","article-title":"The scent of Mycobacterium tuberculosis \u2013 part II breath","volume":"89","author":"Syhre","year":"2009","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.drudis.2009.10.005_bib63","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1128\/iai.62.9.3679-3687.1994","article-title":"T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy","volume":"62","author":"Launois","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.drudis.2009.10.005_bib64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0171-2985(11)80460-2","article-title":"The T cell response to secreted antigens of Mycobacterium tuberculosis","volume":"191","author":"Andersen","year":"1994","journal-title":"Immunobiology"},{"key":"10.1016\/j.drudis.2009.10.005_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4269\/ajtmh.2006.75.55","article-title":"Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda","volume":"75","author":"Whalen","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.drudis.2009.10.005_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20071331","article-title":"An HIV-1 clade C DNA prime. NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"Harari","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib67","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20070784","article-title":"Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover","volume":"204","author":"Almeida","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib68","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5","author":"Hanekom","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.tube.2008.06.005","article-title":"A comparison of IFNgamma detection methods used in tuberculosis vaccine trials","volume":"88","author":"Beveridge","year":"2008","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.drudis.2009.10.005_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/187153008783928398","article-title":"Host\u2013pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention","volume":"8","author":"Lin","year":"2008","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.drudis.2009.10.005_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2334-7-83","article-title":"T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals","volume":"7","author":"Martinez","year":"2007","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib73","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1371\/journal.pone.0000926","article-title":"Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis","volume":"2","author":"Hougardy","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2009.10.005_bib74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/CVI.13.2.179-186.2006","article-title":"Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis","volume":"13","author":"Demissie","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.drudis.2009.10.005_bib75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijid.2007.02.001","article-title":"Correlates for disease progression and prognosis during concurrent HIV\/TB infection","volume":"11","author":"Djoba Siawaya","year":"2007","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ng0308-261","article-title":"Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations","volume":"40","author":"Nejentsev","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.drudis.2009.10.005_bib77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cyto.2008.05.002","article-title":"Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF","volume":"43","author":"Mueller","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.drudis.2009.10.005_bib78","doi-asserted-by":"crossref","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","article-title":"Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection","volume":"4","author":"Schuck","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2009.10.005_bib79","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1164\/rccm.200806-858OC","article-title":"Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"178","author":"Meintjes","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drudis.2009.10.005_bib80","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1073\/pnas.201404898","article-title":"Divergent effect of Bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research","volume":"98","author":"Langermans","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2009.10.005_bib81","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2009.10.005_bib82","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.4049\/jimmunol.180.5.3569","article-title":"Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles","volume":"180","author":"Soares","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2009.10.005_bib83","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/529048","article-title":"Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons","volume":"197","author":"Day","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tim.2006.11.008","article-title":"Vaccine strategies against latent tuberculosis infection","volume":"15","author":"Andersen","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.drudis.2009.10.005_bib85","first-page":"1068","article-title":"Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis","volume":"10","author":"Kaufmann","year":"2006","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.drudis.2009.10.005_bib86","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrmicro1919","article-title":"Systems biology of persistent infection: tuberculosis as a case study","volume":"6","author":"Young","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2009.10.005_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609003444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609003444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:04:27Z","timestamp":1761221067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644609003444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":87,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1359644609003444"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2009.10.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The quest for biomarkers in tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2009.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}